Beijing Suncadia Pharmaceuticals Co., Ltd

Quick facts

Phase 3 pipeline

• SHR-1918 Injection · Oncology
  SHR-1918 is a bispecific antibody that simultaneously engages PD-1 on immune cells and TGF-β in the tumor microenvironment to enhance anti-tumor immunity.
• SHR-2004 injection · Oncology
  SHR-2004 injection is a monoclonal antibody targeting PD-1.

Phase 2 pipeline

• Enoxaparin Sodium Injection; Rivaroxaban Tablets · Cardiovascular
  Enoxaparin sodium injection works by inhibiting Factor Xa and Factor IIa, preventing blood clot formation, while rivaroxaban tablets inhibit Factor Xa directly.
• HRS8179

Phase 1 pipeline

• HRS-4029
• SAD, SHR-2004
• SHR-6934 injection

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Beijing Suncadia Pharmaceuticals Co., Ltd portfolio CI brief
• Beijing Suncadia Pharmaceuticals Co., Ltd pipeline updates RSS